John Gary Csernansky - Publications

Affiliations: 
Northwestern University, Evanston, IL 
Area:
schizophrenia, Alzheimer's Disease

274 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Dong H, Csernansky JG. Editorial: Stress and its impact on Alzheimer's Disease. Neurobiology of Stress. 10: 100167. PMID 31193557 DOI: 10.1016/j.ynstr.2019.100167  0.64
2017 Rodríguez G, Neugebauer NM, Yao KL, Meltzer HY, Csernansky JG, Dong H. Δ9-tetrahydrocannabinol (Δ9-THC) administration after neonatal exposure to phencyclidine potentiates schizophrenia-related behavioral phenotypes in mice. Pharmacology, Biochemistry, and Behavior. PMID 28648819 DOI: 10.1016/j.pbb.2017.06.010  0.64
2017 Gollan JK, Dong H, Bruno D, Nierenberg J, Nobrega JN, Grothe MJ, Pollock BG, Marmar CR, Teipel S, Csernansky JG, Pomara N. Basal forebrain mediated increase in brain CRF is associated with increased cholinergic tone and depression. Psychiatry Research. 264: 76-81. PMID 28477491 DOI: 10.1016/j.pscychresns.2017.04.009  0.64
2017 Montalvo-Ortiz JL, Fisher DW, Rodríguez G, Fang D, Csernansky JG, Dong H. Histone deacetylase inhibitors reverse age-related increases in side effects of haloperidol in mice. Psychopharmacology. PMID 28421257 DOI: 10.1007/s00213-017-4629-2  0.64
2016 Blizinsky KD, Diaz-Castro B, Forrest MP, Schürmann B, Bach AP, Martin-de-Saavedra MD, Wang L, Csernansky JG, Duan J, Penzes P. Reversal of dendritic phenotypes in 16p11.2 microduplication mouse model neurons by pharmacological targeting of a network hub. Proceedings of the National Academy of Sciences of the United States of America. PMID 27402753 DOI: 10.1073/pnas.1607014113  0.72
2015 Gollan JK, Buchanan A, Connolly M, Hoxha D, Sankin L, Csernansky JG, Wang X. Differences in the neural correlates of affective responses in depressed and healthy women. Psychiatry Research. PMID 26490568 DOI: 10.1016/j.pscychresns.2015.10.006  0.72
2015 Herting MM, Uban KA, Williams PL, Gautam P, Huo Y, Malee K, Yogev R, Csernansky J, Wang L, Nichols S, Van Dyke R, Sowell ER. Default Mode Connectivity in Youth With Perinatally Acquired HIV. Medicine. 94: e1417. PMID 26376381 DOI: 10.1097/MD.0000000000001417  0.72
2015 Coccaro EF, Lee R, McCloskey M, Csernansky JG, Wang L. Morphometric analysis of amygdla and hippocampus shape in impulsively aggressive and healthy control subjects. Journal of Psychiatric Research. 69: 80-6. PMID 26343598 DOI: 10.1016/j.jpsychires.2015.07.009  0.72
2015 Gollan JK, Connolly M, Buchanan A, Hoxha D, Rosebrock L, Cacioppo J, Csernansky J, Wang X. Neural substrates of negativity bias in women with and without major depression. Biological Psychology. 109: 184-191. PMID 26073417 DOI: 10.1016/j.biopsycho.2015.06.003  0.72
2015 Smith MJ, Cobia DJ, Reilly JL, Gilman JM, Roberts AG, Alpert KI, Wang L, Breiter HC, Csernansky JG. Cannabis-related episodic memory deficits and hippocampal morphological differences in healthy individuals and schizophrenia subjects. Hippocampus. PMID 25760303 DOI: 10.1002/hipo.22427  0.72
2015 Jarskog LF, Lowy MT, Grove RA, Keefe RS, Horrigan JP, Ball MP, Breier A, Buchanan RW, Carter CS, Csernansky JG, Goff DC, Green MF, Kantrowitz JT, Keshavan MS, Laurelle M, et al. A Phase II study of a histamine H₃ receptor antagonist GSK239512 for cognitive impairment in stable schizophrenia subjects on antipsychotic therapy. Schizophrenia Research. 164: 136-42. PMID 25728831 DOI: 10.1016/j.schres.2015.01.041  0.72
2015 Varghese SP, Montalvo-Ortiz JL, Csernansky JG, Eiger RI, Herrold AA, Koola MM, Dong H. Early Life Stress as a Risk Factor for Substance use Disorders: Clinical and Neurobiological Substrates. Indian Journal of Psychological Medicine. 37: 36-41. PMID 25722510 DOI: 10.4103/0253-7176.150816  0.72
2015 Apostolova LG, Zarow C, Biado K, Hurtz S, Boccardi M, Somme J, Honarpisheh H, Blanken AE, Brook J, Tung S, Lo D, Ng D, Alger JR, Vinters HV, Bocchetta M, et al. Relationship between hippocampal atrophy and neuropathology markers: a 7T MRI validation study of the EADC-ADNI Harmonized Hippocampal Segmentation Protocol. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 11: 139-50. PMID 25620800 DOI: 10.1016/j.jalz.2015.01.001  0.72
2015 Harms MP, Akhter KD, Csernansky JG, Mori S, Barch DM. Fractional anisotropy in individuals with schizophrenia and their nonpsychotic siblings. Psychiatry Research. 231: 87-91. PMID 25453989 DOI: 10.1016/j.pscychresns.2014.10.009  0.72
2015 Frisoni GB, Jack CR, Bocchetta M, Bauer C, Frederiksen KS, Liu Y, Preboske G, Swihart T, Blair M, Cavedo E, Grothe MJ, Lanfredi M, Martinez O, Nishikawa M, Portegies M, ... ... Csernansky JG, et al. The EADC-ADNI Harmonized Protocol for manual hippocampal segmentation on magnetic resonance: evidence of validity. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 11: 111-25. PMID 25267715 DOI: 10.1016/j.jalz.2014.05.1756  0.72
2015 Smith MJ, Schroeder MP, Abram SV, Goldman MB, Parrish TB, Wang X, Derntl B, Habel U, Decety J, Reilly JL, Csernansky JG, Breiter HC. Alterations in brain activation during cognitive empathy are related to social functioning in schizophrenia. Schizophrenia Bulletin. 41: 211-22. PMID 24583906 DOI: 10.1093/schbul/sbu023  0.72
2015 Boccardi M, Bocchetta M, Ganzola R, Robitaille N, Redolfi A, Duchesne S, Jack CR, Frisoni GB, Bartzokis G, Csernansky JG, De Leon MJ, Detoledo-Morrell L, Killiany RJ, Lehericy S, Malykhin N, et al. Operationalizing protocol differences for EADC-ADNI manual hippocampal segmentation Alzheimer's and Dementia. 11: 184-194. DOI: 10.1016/j.jalz.2013.03.001  0.72
2014 Barch DM, Cohen R, Csernansky J. Altered cognitive development in the siblings of individuals with schizophrenia. Clinical Psychological Science : a Journal of the Association For Psychological Science. 2: 138-151. PMID 25485180 DOI: 10.1177/2167702613496244  0.72
2014 Russell TA, Blizinsky KD, Cobia DJ, Cahill ME, Xie Z, Sweet RA, Duan J, Gejman PV, Wang L, Csernansky JG, Penzes P. A sequence variant in human KALRN impairs protein function and coincides with reduced cortical thickness. Nature Communications. 5: 4858. PMID 25224588 DOI: 10.1038/ncomms5858  0.72
2014 Womer FY, Wang L, Alpert KI, Smith MJ, Csernansky JG, Barch DM, Mamah D. Basal ganglia and thalamic morphology in schizophrenia and bipolar disorder. Psychiatry Research. 223: 75-83. PMID 24957866 DOI: 10.1016/j.pscychresns.2014.05.017  0.72
2014 Dong H, Wang S, Zeng Z, Li F, Montalvo-Ortiz J, Tucker C, Akhtar S, Shi J, Meltzer HY, Rice KC, Csernansky JG. Effects of corticotrophin-releasing factor receptor 1 antagonists on amyloid-β and behavior in Tg2576 mice. Psychopharmacology. 231: 4711-22. PMID 24862368 DOI: 10.1007/s00213-014-3629-8  0.72
2014 Csernansky JG, Soares J. Abstracts of the 69th Annual Scientific Meeting of the Society of Biological Psychiatry, May 8-12, 2014, New York City, New York. Biological Psychiatry. 75: S1-401. PMID 24731725 DOI: 10.1016/j.biopsych.2014.02.002  0.72
2014 Montalvo-Ortiz JL, Keegan J, Gallardo C, Gerst N, Tetsuka K, Tucker C, Matsumoto M, Fang D, Csernansky JG, Dong H. HDAC inhibitors restore the capacity of aged mice to respond to haloperidol through modulation of histone acetylation. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 1469-78. PMID 24366052 DOI: 10.1038/npp.2013.346  0.72
2014 Smith MJ, Cobia DJ, Wang L, Alpert KI, Cronenwett WJ, Goldman MB, Mamah D, Barch DM, Breiter HC, Csernansky JG. Cannabis-related working memory deficits and associated subcortical morphological differences in healthy individuals and schizophrenia subjects. Schizophrenia Bulletin. 40: 287-99. PMID 24342821 DOI: 10.1093/schbul/sbt176  0.72
2014 Wang L, Csernansky JG. Recent advances in neuroimaging biomarkers of schizophrenia Schizophrenia: Recent Advances in Diagnosis and Treatment. 71-103. DOI: 10.1007/978-1-4939-0656-7_6  0.72
2013 Cronenwett WJ, Csernansky JG. Diving deep into white matter to improve our understanding of the pathophysiology of schizophrenia. Biological Psychiatry. 74: 396-7. PMID 23968985 DOI: 10.1016/j.biopsych.2013.07.007  0.72
2013 Jarskog LF, Dong Z, Kangarlu A, Colibazzi T, Girgis RR, Kegeles LS, Barch DM, Buchanan RW, Csernansky JG, Goff DC, Harms MP, Javitt DC, Keefe RS, McEvoy JP, McMahon RP, et al. Effects of davunetide on N-acetylaspartate and choline in dorsolateral prefrontal cortex in patients with schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 38: 1245-52. PMID 23325325 DOI: 10.1038/npp.2013.23  0.72
2013 Ceaser A, Csernansky JG, Barch DM. COMT influences on prefrontal and striatal blood oxygenation level-dependent responses during working memory among individuals with schizophrenia, their siblings, and healthy controls. Cognitive Neuropsychiatry. 18: 257-83. PMID 23030509 DOI: 10.1080/13546805.2012.698100  0.72
2013 Selemon LD, Ceritoglu C, Ratnanather JT, Wang L, Harms MP, Aldridge K, Begović A, Csernansky JG, Miller MI, Rakic P. Distinct abnormalities of the primate prefrontal cortex caused by ionizing radiation in early or midgestation. The Journal of Comparative Neurology. 521: 1040-53. PMID 22911497 DOI: 10.1002/cne.23217  0.72
2013 Harms MP, Wang L, Csernansky JG, Barch DM. Structure-function relationship of working memory activity with hippocampal and prefrontal cortex volumes. Brain Structure & Function. 218: 173-86. PMID 22362200 DOI: 10.1007/s00429-012-0391-8  0.72
2012 Aldridge K, Wang L, Harms MP, Moffitt AJ, Cole KK, Csernansky JG, Selemon LD. A longitudinal analysis of regional brain volumes in macaques exposed to X-irradiation in early gestation. Plos One. 7: e43109. PMID 22905212 DOI: 10.1371/journal.pone.0043109  0.72
2012 Turner JA, Calhoun VD, Michael A, van Erp TG, Ehrlich S, Segall JM, Gollub RL, Csernansky J, Potkin SG, Ho BC, Bustillo J, Schulz SC, FBIRN, Wang L. Heritability of multivariate gray matter measures in schizophrenia. Twin Research and Human Genetics : the Official Journal of the International Society For Twin Studies. 15: 324-35. PMID 22856368 DOI: 10.1017/thg.2012.1  0.72
2012 Cobia DJ, Smith MJ, Wang L, Csernansky JG. Longitudinal progression of frontal and temporal lobe changes in schizophrenia. Schizophrenia Research. 139: 1-6. PMID 22647883 DOI: 10.1016/j.schres.2012.05.002  0.72
2012 Karnik-Henry MS, Wang L, Barch DM, Harms MP, Campanella C, Csernansky JG. Medial temporal lobe structure and cognition in individuals with schizophrenia and in their non-psychotic siblings. Schizophrenia Research. 138: 128-35. PMID 22542243 DOI: 10.1016/j.schres.2012.03.015  0.72
2012 Smith MJ, Horan WP, Karpouzian TM, Abram SV, Cobia DJ, Csernansky JG. Self-reported empathy deficits are uniquely associated with poor functioning in schizophrenia. Schizophrenia Research. 137: 196-202. PMID 22321668 DOI: 10.1016/j.schres.2012.01.012  0.72
2012 Javitt DC, Buchanan RW, Keefe RS, Kern R, McMahon RP, Green MF, Lieberman J, Goff DC, Csernansky JG, McEvoy JP, Jarskog F, Seidman LJ, Gold JM, Kimhy D, Nolan KS, et al. Effect of the neuroprotective peptide davunetide (AL-108) on cognition and functional capacity in schizophrenia. Schizophrenia Research. 136: 25-31. PMID 22169248 DOI: 10.1016/j.schres.2011.11.001  0.72
2012 Wang L, Fagan AM, Shah AR, Beg MF, Csernansky JG, Morris JC, Holtzman DM. Cerebrospinal fluid proteins predict longitudinal hippocampal degeneration in early-stage dementia of the Alzheimer type. Alzheimer Disease and Associated Disorders. 26: 314-21. PMID 22156755 DOI: 10.1097/WAD.0b013e31823c0cf4  0.72
2012 Dong H, Murphy KM, Meng L, Montalvo-Ortiz J, Zeng Z, Kolber BJ, Zhang S, Muglia LJ, Csernansky JG. Corticotrophin releasing factor accelerates neuropathology and cognitive decline in a mouse model of Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 28: 579-92. PMID 22045495 DOI: 10.3233/JAD-2011-111328  0.72
2012 Ceyhan E, Beg MF, CeritoÄŸlu C, Wang L, Morris JC, Csernansky JG, Miller MI, Ratnanather JT. Metric distances between hippocampal shapes indicate different rates of change over time in nondemented and demented subjects. Current Alzheimer Research. 9: 972-81. PMID 21875412 DOI: 10.2174/156720512803251138  0.72
2012 Smith MJ, Csernansky JG. Clinical implications of alcohol-use disorders in schizophrenia Neuropsychiatry. 2: 239-252. DOI: 10.2217/npy.12.21  0.72
2011 Glick ID, Correll CU, Altamura AC, Marder SR, Csernansky JG, Weiden PJ, Leucht S, Davis JM. Mid-term and long-term efficacy and effectiveness of antipsychotic medications for schizophrenia: a data-driven, personalized clinical approach. The Journal of Clinical Psychiatry. 72: 1616-27. PMID 22244023 DOI: 10.4088/JCP.11r06927  0.72
2011 Rhee Y, Csernansky JG, Emanuel LL, Chang CG, Shega JW. Psychotropic medication burden and factors associated with antipsychotic use: an analysis of a population-based sample of community-dwelling older persons with dementia. Journal of the American Geriatrics Society. 59: 2100-7. PMID 22092099 DOI: 10.1111/j.1532-5415.2011.03660.x  0.72
2011 Xiong C, Roe CM, Buckles V, Fagan A, Holtzman D, Balota D, Duchek J, Storandt M, Mintun M, Grant E, Snyder AZ, Head D, Benzinger TL, Mettenburg J, Csernansky J, et al. Role of family history for Alzheimer biomarker abnormalities in the adult children study. Archives of Neurology. 68: 1313-9. PMID 21987546 DOI: 10.1001/archneurol.2011.208  0.72
2011 Cobia DJ, Csernansky JG, Wang L. Cortical thickness in neuropsychologically near-normal schizophrenia. Schizophrenia Research. 133: 68-76. PMID 21981933 DOI: 10.1016/j.schres.2011.08.017  0.72
2011 Boccardi M, Ganzola R, Bocchetta M, Pievani M, Redolfi A, Bartzokis G, Camicioli R, Csernansky JG, de Leon MJ, deToledo-Morrell L, Killiany RJ, Lehéricy S, Pantel J, Pruessner JC, Soininen H, et al. Survey of protocols for the manual segmentation of the hippocampus: preparatory steps towards a joint EADC-ADNI harmonized protocol. Journal of Alzheimer's Disease : Jad. 26: 61-75. PMID 21971451 DOI: 10.3233/JAD-2011-0004  0.72
2011 Smith MJ, Wang L, Cronenwett W, Goldman MB, Mamah D, Barch DM, Csernansky JG. Alcohol use disorders contribute to hippocampal and subcortical shape differences in schizophrenia. Schizophrenia Research. 131: 174-83. PMID 21658914 DOI: 10.1016/j.schres.2011.05.014  0.72
2011 Meng L, Lu L, Murphy KM, Yuede CM, Cheverud JM, Csernansky JG, Dong H. Neuroanatomic and behavioral traits for autistic disorders in age-specific restricted index selection mice. Neuroscience. 189: 215-22. PMID 21624435 DOI: 10.1016/j.neuroscience.2011.05.017  0.72
2011 Zarow C, Wang L, Chui HC, Weiner MW, Csernansky JG. MRI shows more severe hippocampal atrophy and shape deformation in hippocampal sclerosis than in Alzheimer's disease. International Journal of Alzheimer's Disease. 2011: 483972. PMID 21547227 DOI: 10.4061/2011/483972  0.72
2011 Essock SM, Schooler NR, Stroup TS, McEvoy JP, Rojas I, Jackson C, Covell NH, Adler L, Byerly M, Caroff S, Csernansky J, D'Souza C, Manschreck T, McEvoy J, Miller A, et al. Effectiveness of switching from antipsychotic polypharmacy to monotherapy American Journal of Psychiatry. 168: 702-708. PMID 21536693 DOI: 10.1176/appi.ajp.2011.10060908  0.72
2011 Ceyhan E, Beg MF, Ceritoglu C, Wang L, Morris JC, Csernansky JG, Miller MI, Ratnanather JT. Quantization and analysis of hippocampal morphometric changes due to dementia of Alzheimer type using metric distances based on large deformation diffeomorphic metric mapping. Computerized Medical Imaging and Graphics : the Official Journal of the Computerized Medical Imaging Society. 35: 275-93. PMID 21345652 DOI: 10.1016/j.compmedimag.2011.01.005  0.72
2011 Csernansky JG, Smith MJ. Thought, feeling, and action in real time--monitoring of drug use in schizophrenia. The American Journal of Psychiatry. 168: 120-2. PMID 21297046 DOI: 10.1176/appi.ajp.2010.10111601  0.72
2011 Repovs G, Csernansky JG, Barch DM. Brain network connectivity in individuals with schizophrenia and their siblings. Biological Psychiatry. 69: 967-73. PMID 21193174 DOI: 10.1016/j.biopsych.2010.11.009  0.72
2011 Buchanan RW, Keefe RS, Lieberman JA, Barch DM, Csernansky JG, Goff DC, Gold JM, Green MF, Jarskog LF, Javitt DC, Kimhy D, Kraus MS, McEvoy JP, Mesholam-Gately RI, Seidman LJ, et al. A randomized clinical trial of MK-0777 for the treatment of cognitive impairments in people with schizophrenia. Biological Psychiatry. 69: 442-9. PMID 21145041 DOI: 10.1016/j.biopsych.2010.09.052  0.72
2011 Goldman MB, Wang L, Wachi C, Daudi S, Csernansky J, Marlow-O'Connor M, Keedy S, Torres I. Structural pathology underlying neuroendocrine dysfunction in schizophrenia. Behavioural Brain Research. 218: 106-13. PMID 21093493 DOI: 10.1016/j.bbr.2010.11.025  0.72
2011 Smith MJ, Wang L, Cronenwett W, Mamah D, Barch DM, Csernansky JG. Thalamic morphology in schizophrenia and schizoaffective disorder. Journal of Psychiatric Research. 45: 378-85. PMID 20797731 DOI: 10.1016/j.jpsychires.2010.08.003  0.72
2010 Cronenwett WJ, Csernansky J. Thalamic pathology in schizophrenia Current Topics in Behavioral Neurosciences. 4: 509-528. PMID 21312411 DOI: 10.1007/7854_2010_55  0.72
2010 March J, Kraemer HC, Trivedi M, Csernansky J, Davis J, Ketter TA, Glick ID. What have we learned about trial design from NIMH-funded pragmatic trials? Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 2491-501. PMID 20736990 DOI: 10.1038/npp.2010.115  0.72
2010 Mamah D, Conturo TE, Harms MP, Akbudak E, Wang L, McMichael AR, Gado MH, Barch DM, Csernansky JG. Anterior thalamic radiation integrity in schizophrenia: a diffusion-tensor imaging study. Psychiatry Research. 183: 144-50. PMID 20619618 DOI: 10.1016/j.pscychresns.2010.04.013  0.72
2010 Ceritoglu C, Wang L, Selemon LD, Csernansky JG, Miller MI, Ratnanather JT. Large Deformation Diffeomorphic Metric Mapping Registration of Reconstructed 3D Histological Section Images and in vivo MR Images. Frontiers in Human Neuroscience. 4: 43. PMID 20577633 DOI: 10.3389/fnhum.2010.00043  0.72
2010 Karnik MS, Wang L, Barch DM, Morris JC, Csernansky JG. BDNF polymorphism rs6265 and hippocampal structure and memory performance in healthy control subjects. Psychiatry Research. 178: 425-9. PMID 20493546 DOI: 10.1016/j.psychres.2009.09.008  0.72
2010 Harms MP, Wang L, Campanella C, Aldridge K, Moffitt AJ, Kuelper J, Ratnanather JT, Miller MI, Barch DM, Csernansky JG. Structural abnormalities in gyri of the prefrontal cortex in individuals with schizophrenia and their unaffected siblings. The British Journal of Psychiatry : the Journal of Mental Science. 196: 150-7. PMID 20118463 DOI: 10.1192/bjp.bp.109.067314  0.72
2010 Anticevic A, Repovs G, Van Snellenberg JX, Csernansky JG, Barch DM. Subcortical alignment precision in patients with schizophrenia. Schizophrenia Research. 120: 76-83. PMID 20097545 DOI: 10.1016/j.schres.2009.12.040  0.72
2010 Wang L, Harms MP, Staggs JM, Xiong C, Morris JC, Csernansky JG, Galvin JE. Donepezil treatment and changes in hippocampal structure in very mild Alzheimer disease. Archives of Neurology. 67: 99-106. PMID 20065136 DOI: 10.1001/archneurol.2009.292  0.72
2010 Marcus DS, Fotenos AF, Csernansky JG, Morris JC, Buckner RL. Open access series of imaging studies: longitudinal MRI data in nondemented and demented older adults. Journal of Cognitive Neuroscience. 22: 2677-84. PMID 19929323 DOI: 10.1162/jocn.2009.21407  0.72
2010 Harms MP, Wang L, Campanella C, Aldridge K, Moffitt AJ, Kuelper J, Ratnanather JT, Miller MI, Barch DM, Csernansky JG. Authors' reply British Journal of Psychiatry. 196: 414-415. DOI: 10.1192/bjp.196.5.414a  0.72
2009 Swantek SS, Csernansky JG. Genetic biomarkers for dementia-related processes: how close are the authors? The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 17: 823-5. PMID 19910871 DOI: 10.1097/JGP.0b013e3181b6dd06  0.72
2009 Lipkovich IA, Deberdt W, Csernansky JG, Buckley P, Peuskens J, Kollack-Walker S, Rotelli M, Houston JP. Defining "good" and "poor" outcomes in patients with schizophrenia or schizoaffective disorder: a multidimensional data-driven approach. Psychiatry Research. 170: 161-7. PMID 19897252 DOI: 10.1016/j.psychres.2008.09.004  0.72
2009 Dong H, Yuede CM, Coughlan CA, Murphy KM, Csernansky JG. Effects of donepezil on amyloid-beta and synapse density in the Tg2576 mouse model of Alzheimer's disease. Brain Research. 1303: 169-78. PMID 19799879 DOI: 10.1016/j.brainres.2009.09.097  0.72
2009 Lipkovich IA, Deberdt W, Csernansky JG, Sabbe B, Keefe RS, Kollack-Walker S. Relationships among neurocognition, symptoms and functioning in patients with schizophrenia: a path-analytic approach for associations at baseline and following 24 weeks of antipsychotic drug therapy. Bmc Psychiatry. 9: 44. PMID 19602273 DOI: 10.1186/1471-244X-9-44  0.72
2009 Dong H, Csernansky JG. Effects of stress and stress hormones on amyloid-beta protein and plaque deposition. Journal of Alzheimer's Disease : Jad. 18: 459-69. PMID 19584430 DOI: 10.3233/JAD-2009-1152  0.72
2009 Yuede CM, Zimmerman SD, Dong H, Kling MJ, Bero AW, Holtzman DM, Timson BF, Csernansky JG. Effects of voluntary and forced exercise on plaque deposition, hippocampal volume, and behavior in the Tg2576 mouse model of Alzheimer's disease. Neurobiology of Disease. 35: 426-32. PMID 19524672 DOI: 10.1016/j.nbd.2009.06.002  0.72
2009 Qiu A, Wang L, Younes L, Harms MP, Ratnanather JT, Miller MI, Csernansky JG. Neuroanatomical asymmetry patterns in individuals with schizophrenia and their non-psychotic siblings. Neuroimage. 47: 1221-9. PMID 19481156 DOI: 10.1016/j.neuroimage.2009.05.054  0.72
2009 Wang L, Khan A, Csernansky JG, Fischl B, Miller MI, Morris JC, Beg MF. Fully-automated, multi-stage hippocampus mapping in very mild Alzheimer disease. Hippocampus. 19: 541-8. PMID 19405129 DOI: 10.1002/hipo.20616  0.72
2009 Chen LS, Rice TK, Thompson PA, Barch DM, Csernansky JG. Familial aggregation of clinical and neurocognitive features in sibling pairs with and without schizophrenia. Schizophrenia Research. 111: 159-66. PMID 19398304 DOI: 10.1016/j.schres.2009.03.030  0.72
2009 Lieberman JA, Papadakis K, Csernansky J, Litman R, Volavka J, Jia XD, Gage A. A randomized, placebo-controlled study of memantine as adjunctive treatment in patients with schizophrenia Neuropsychopharmacology. 34: 1322-1329. PMID 19005465 DOI: 10.1038/npp.2008.200  0.72
2009 Geller B, Harms MP, Wang L, Tillman R, DelBello MP, Bolhofner K, Csernansky JG. Effects of age, sex, and independent life events on amygdala and nucleus accumbens volumes in child bipolar I disorder. Biological Psychiatry. 65: 432-7. PMID 18990366 DOI: 10.1016/j.biopsych.2008.09.033  0.72
2009 Smith MJ, Barch DM, Csernansky JG. Bridging the gap between schizophrenia and psychotic mood disorders: Relating neurocognitive deficits to psychopathology. Schizophrenia Research. 107: 69-75. PMID 18786811 DOI: 10.1016/j.schres.2008.07.014  0.72
2009 Martin MV, Churchill JD, Dong H, Wozniak DF, Cheverud JM, Csernansky JG. Genetic influences on hippocampal structure and function in recombinant inbred mice. Behavioural Brain Research. 196: 78-83. PMID 18721828 DOI: 10.1016/j.bbr.2008.07.029  0.72
2009 Lyskowski JC, Menditto AA, Csernansky JG. Treatment of violent behavior in patients with Combined psychiatric illness and cognitive impairment: A case series Mental Health Aspects of Developmental Disabilities. 12: 8-16.  0.72
2008 Lieberman JA, Bymaster FP, Meltzer HY, Deutch AY, Duncan GE, Marx CE, Aprille JR, Dwyer DS, Li XM, Mahadik SP, Duman RS, Porter JH, Modica-Napolitano JS, Newton SS, Csernansky JG. Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection. Pharmacological Reviews. 60: 358-403. PMID 18922967 DOI: 10.1124/pr.107.00107  0.72
2008 Tepest R, Wang L, Csernansky JG, Neubert P, Heun R, Scheef L, Jessen F. Hippocampal surface analysis in subjective memory impairment, mild cognitive impairment and Alzheimer's dementia. Dementia and Geriatric Cognitive Disorders. 26: 323-9. PMID 18841017 DOI: 10.1159/000161057  0.72
2008 Wang L, Mamah D, Harms MP, Karnik M, Price JL, Gado MH, Thompson PA, Barch DM, Miller MI, Csernansky JG. Progressive deformation of deep brain nuclei and hippocampal-amygdala formation in schizophrenia. Biological Psychiatry. 64: 1060-8. PMID 18814865 DOI: 10.1016/j.biopsych.2008.08.007  0.72
2008 Bonner-Jackson A, Yodkovik N, Csernansky JG, Barch DM. Episodic memory in schizophrenia: the influence of strategy use on behavior and brain activation. Psychiatry Research. 164: 1-15. PMID 18790618 DOI: 10.1016/j.pscychresns.2007.12.012  0.72
2008 Smith MJ, Barch DM, Wolf TJ, Mamah D, Csernansky JG. Elevated rates of substance use disorders in non-psychotic siblings of individuals with schizophrenia. Schizophrenia Research. 106: 294-9. PMID 18774264 DOI: 10.1016/j.schres.2008.07.015  0.72
2008 Smith MJ, Cloninger CR, Harms MP, Csernansky JG. Temperament and character as schizophrenia-related endophenotypes in non-psychotic siblings. Schizophrenia Research. 104: 198-205. PMID 18718739 DOI: 10.1016/j.schres.2008.06.025  0.72
2008 Csernansky JG, Gillespie SK, Dierker DL, Anticevic A, Wang L, Barch DM, Van Essen DC. Symmetric abnormalities in sulcal patterning in schizophrenia. Neuroimage. 43: 440-6. PMID 18707008 DOI: 10.1016/j.neuroimage.2008.07.034  0.72
2008 Calabrese DR, Wang L, Harms MP, Ratnanather JT, Barch DM, Cloninger CR, Thompson PA, Miller MI, Csernansky JG. Cingulate gyrus neuroanatomy in schizophrenia subjects and their non-psychotic siblings. Schizophrenia Research. 104: 61-70. PMID 18692994 DOI: 10.1016/j.schres.2008.06.014  0.72
2008 Csernansky JG, Cronenwett WJ. Neural networks in schizophrenia. The American Journal of Psychiatry. 165: 937-9. PMID 18676594 DOI: 10.1176/appi.ajp.2008.08050700  0.72
2008 Dong H, Yuede CM, Yoo HS, Martin MV, Deal C, Mace AG, Csernansky JG. Corticosterone and related receptor expression are associated with increased beta-amyloid plaques in isolated Tg2576 mice. Neuroscience. 155: 154-63. PMID 18571864 DOI: 10.1016/j.neuroscience.2008.05.017  0.72
2008 Smith MJ, Barch DM, Thompson PA, Csernansky JG. Subclinical expression of schizophrenia-like symptoms in non-psychotic siblings of individuals with schizophrenia. Schizophrenia Research. 103: 324-5. PMID 18550340 DOI: 10.1016/j.schres.2008.04.028  0.72
2008 Anticevic A, Dierker DL, Gillespie SK, Repovs G, Csernansky JG, Van Essen DC, Barch DM. Comparing surface-based and volume-based analyses of functional neuroimaging data in patients with schizophrenia. Neuroimage. 41: 835-48. PMID 18434199 DOI: 10.1016/j.neuroimage.2008.02.052  0.72
2008 Dong H, Yuede CM, Coughlan C, Lewis B, Csernansky JG. Effects of memantine on neuronal structure and conditioned fear in the Tg2576 mouse model of Alzheimer's disease. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 33: 3226-36. PMID 18418360 DOI: 10.1038/npp.2008.53  0.72
2008 Mamah D, Harms MP, Wang L, Barch D, Thompson P, Kim J, Miller MI, Csernansky JG. Basal ganglia shape abnormalities in the unaffected siblings of schizophrenia patients. Biological Psychiatry. 64: 111-20. PMID 18295189 DOI: 10.1016/j.biopsych.2008.01.004  0.72
2008 Qiu A, Younes L, Miller MI, Csernansky JG. Parallel transport in diffeomorphisms distinguishes the time-dependent pattern of hippocampal surface deformation due to healthy aging and the dementia of the Alzheimer's type. Neuroimage. 40: 68-76. PMID 18249009 DOI: 10.1016/j.neuroimage.2007.11.041  0.72
2008 Delawalla Z, Csernansky JG, Barch DM. Prefrontal cortex function in nonpsychotic siblings of individuals with schizophrenia. Biological Psychiatry. 63: 490-7. PMID 17631280 DOI: 10.1016/j.biopsych.2007.05.007  0.72
2008 Lieberman JA, Bymaster FP, Meltzer HY, Deutch AY, Duncan GE, Marx CE, Aprille JR, Dwyer DS, Li XM, Mahadik SP, Duman RS, Porter JH, Modica-Napolitano JS, Newton SS, Csernansky JG. Antipsychotic drugs: Comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection (Pharmacological Reviews (2002) 60, (358-403)) Pharmacological Reviews. 60: 582.  0.72
2007 Harms MP, Wang L, Mamah D, Barch DM, Thompson PA, Csernansky JG. Thalamic shape abnormalities in individuals with schizophrenia and their nonpsychotic siblings. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 13835-42. PMID 18077695 DOI: 10.1523/JNEUROSCI.2571-07.2007  0.72
2007 John JP, Yashavantha BS, Gado M, Veena R, Jain S, Ravishankar S, Csernansky JG. A proposal for MRI-based parcellation of the frontal pole. Brain Structure & Function. 212: 245-53. PMID 17929054 DOI: 10.1007/s00429-007-0157-x  0.72
2007 Yuede CM, Dong H, Csernansky JG. Anti-dementia drugs and hippocampal-dependent memory in rodents. Behavioural Pharmacology. 18: 347-63. PMID 17762506 DOI: 10.1097/FBP.0b013e3282da278d  0.72
2007 Marcus DS, Wang TH, Parker J, Csernansky JG, Morris JC, Buckner RL. Open Access Series of Imaging Studies (OASIS): cross-sectional MRI data in young, middle aged, nondemented, and demented older adults. Journal of Cognitive Neuroscience. 19: 1498-507. PMID 17714011 DOI: 10.1162/jocn.2007.19.9.1498  0.72
2007 Barch DM, Csernansky JG. Abnormal parietal cortex activation during working memory in schizophrenia: verbal phonological coding disturbances versus domain-general executive dysfunction. The American Journal of Psychiatry. 164: 1090-8. PMID 17606661 DOI: 10.1176/appi.ajp.164.7.1090  0.72
2007 Kang JE, Cirrito JR, Dong H, Csernansky JG, Holtzman DM. Acute stress increases interstitial fluid amyloid-beta via corticotropin-releasing factor and neuronal activity. Proceedings of the National Academy of Sciences of the United States of America. 104: 10673-8. PMID 17551018 DOI: 10.1073/pnas.0700148104  0.72
2007 Wang L, Hosakere M, Trein JC, Miller A, Ratnanather JT, Barch DM, Thompson PA, Qiu A, Gado MH, Miller MI, Csernansky JG. Abnormalities of cingulate gyrus neuroanatomy in schizophrenia. Schizophrenia Research. 93: 66-78. PMID 17433626 DOI: 10.1016/j.schres.2007.02.021  0.72
2007 Wang L, Beg F, Ratnanather T, Ceritoglu C, Younes L, Morris JC, Csernansky JG, Miller MI. Large deformation diffeomorphism and momentum based hippocampal shape discrimination in dementia of the Alzheimer type. Ieee Transactions On Medical Imaging. 26: 462-70. PMID 17427733 DOI: 10.1109/TMI.2005.853923  0.72
2007 Dager SR, Wang L, Friedman SD, Shaw DW, Constantino JN, Artru AA, Dawson G, Csernansky JG. Shape mapping of the hippocampus in young children with autism spectrum disorder. Ajnr. American Journal of Neuroradiology. 28: 672-7. PMID 17416819  0.72
2007 Dong H, Martin MV, Colvin J, Ali Z, Wang L, Lu L, Williams RW, Rosen GD, Csernansky JG, Cheverud JM. Quantitative trait loci linked to thalamus and cortex gray matter volumes in BXD recombinant inbred mice. Heredity. 99: 62-9. PMID 17406662 DOI: 10.1038/sj.hdy.6800965  0.72
2007 Csernansky JG. Neurodegeneration in schizophrenia: evidence from in vivo neuroimaging studies. Thescientificworldjournal. 7: 135-43. PMID 17334606 DOI: 10.1100/tsw.2007.47  0.72
2007 Bonner-Jackson A, Csernansky JG, Barch DM. Levels-of-processing effects in first-degree relatives of individuals with schizophrenia. Biological Psychiatry. 61: 1141-7. PMID 17123479 DOI: 10.1016/j.biopsych.2006.07.006  0.72
2007 Dong H, Martin MV, Chambers S, Csernansky JG. Spatial relationship between synapse loss and beta-amyloid deposition in Tg2576 mice. The Journal of Comparative Neurology. 500: 311-21. PMID 17111375 DOI: 10.1002/cne.21176  0.72
2007 Mamah D, Wang L, Barch D, de Erausquin GA, Gado M, Csernansky JG. Structural analysis of the basal ganglia in schizophrenia. Schizophrenia Research. 89: 59-71. PMID 17071057 DOI: 10.1016/j.schres.2006.08.031  0.72
2007 Lipkovich I, Deberdt W, Csernansky JG, Buckley P, Peuskens J, Kollack-Walker S, Zhang Y, Liu-Seifert H, Houston JP. Predictors of risk for relapse in patients with schizophrenia or schizoaffective disorder during olanzapine drug therapy. Journal of Psychiatric Research. 41: 305-10. PMID 17010994 DOI: 10.1016/j.jpsychires.2006.07.016  0.72
2007 Wang L, Hosakere M, Trein JCL, Miller A, Ratnanather JT, Barch DM, Thompson PA, Qiu A, Gado MH, Miller MI, Csernansky JG. Corrigendum to "Abnormalities of cingulate gyrus neuroanatomy in schizophrenia" [Schizophrenia Research 93 (1-3) (2007) 66-78] (DOI:10.1016/j.schres.2007.02.021) Schizophrenia Research. 94: 380. DOI: 10.1016/j.schres.2007.05.016  0.72
2006 Csernansky JG, Dong H, Fagan AM, Wang L, Xiong C, Holtzman DM, Morris JC. Plasma cortisol and progression of dementia in subjects with Alzheimer-type dementia. The American Journal of Psychiatry. 163: 2164-9. PMID 17151169 DOI: 10.1176/appi.ajp.163.12.2164  0.72
2006 Hogan RE, Wang L, Bertrand ME, Willmore LJ, Bucholz RD, Nassif AS, Csernansky JG. Predictive value of hippocampal MR imaging-based high-dimensional mapping in mesial temporal epilepsy: preliminary findings. Ajnr. American Journal of Neuroradiology. 27: 2149-54. PMID 17110686  0.72
2006 John JP, Wang L, Moffitt AJ, Singh HK, Gado MH, Csernansky JG. Inter-rater reliability of manual segmentation of the superior, inferior and middle frontal gyri. Psychiatry Research. 148: 151-63. PMID 17088050 DOI: 10.1016/j.pscychresns.2006.05.006  0.72
2006 Martin MV, Dong H, Vallera D, Lee D, Lu L, Williams RW, Rosen GD, Cheverud JM, Csernansky JG. Independent quantitative trait loci influence ventral and dorsal hippocampal volume in recombinant inbred strains of mice. Genes, Brain, and Behavior. 5: 614-23. PMID 17081266 DOI: 10.1111/j.1601-183X.2006.00215.x  0.72
2006 Brahmbhatt SB, Haut K, Csernansky JG, Barch DM. Neural correlates of verbal and nonverbal working memory deficits in individuals with schizophrenia and their high-risk siblings. Schizophrenia Research. 87: 191-204. PMID 16842976 DOI: 10.1016/j.schres.2006.05.019  0.72
2006 Delawalla Z, Barch DM, Fisher Eastep JL, Thomason ES, Hanewinkel MJ, Thompson PA, Csernansky JG. Factors mediating cognitive deficits and psychopathology among siblings of individuals with schizophrenia. Schizophrenia Bulletin. 32: 525-37. PMID 16714471 DOI: 10.1093/schbul/sbj082  0.72
2006 Csernansky JG, Martin MV, Czeisler B, Meltzer MA, Ali Z, Dong H. Neuroprotective effects of olanzapine in a rat model of neurodevelopmental injury. Pharmacology, Biochemistry, and Behavior. 83: 208-13. PMID 16524622 DOI: 10.1016/j.pbb.2006.01.009  0.72
2006 Andrews J, Wang L, Csernansky JG, Gado MH, Barch DM. Abnormalities of thalamic activation and cognition in schizophrenia. The American Journal of Psychiatry. 163: 463-9. PMID 16513868 DOI: 10.1176/appi.ajp.163.3.463  0.72
2006 Wang L, Miller JP, Gado MH, McKeel DW, Rothermich M, Miller MI, Morris JC, Csernansky JG. Abnormalities of hippocampal surface structure in very mild dementia of the Alzheimer type. Neuroimage. 30: 52-60. PMID 16243546 DOI: 10.1016/j.neuroimage.2005.09.017  0.72
2006 Csernansky JG, Martin MV, Czeisler B, Meltzer MA, Ali Z, Dong H. Corrigendum to "Neuroprotective effects of olanzapine in a rat model of neurodevelopmental injury" [Pharmacol Biochem Behav 83 (2006) 208-213] (DOI:10.1016/j.pbb.2006.01.009) Pharmacology Biochemistry and Behavior. 84: 543. DOI: 10.1016/j.pbb.2006.07.016  0.72
2005 Csernansky JG, Wang L, Miller JP, Galvin JE, Morris JC. Neuroanatomical predictors of response to donepezil therapy in patients with dementia. Archives of Neurology. 62: 1718-22. PMID 16286546 DOI: 10.1001/archneur.62.11.1718  0.72
2005 Martin MV, Dong H, Bertchume A, Csernansky JG. Low dose quetiapine reverses deficits in contextual and cued fear conditioning in rats with excitotoxin-induced hippocampal neuropathy. Pharmacology, Biochemistry, and Behavior. 82: 263-9. PMID 16183107 DOI: 10.1016/j.pbb.2005.08.010  0.72
2005 Melinder MR, Barch DM, Heydebrand G, Csernansky JG. Easier tasks can have better discriminating power: the case of verbal fluency. Journal of Abnormal Psychology. 114: 385-91. PMID 16117575 DOI: 10.1037/0021-843X.114.3.383  0.72
2005 Bonner-Jackson A, Haut K, Csernansky JG, Barch DM. The influence of encoding strategy on episodic memory and cortical activity in schizophrenia. Biological Psychiatry. 58: 47-55. PMID 15992522 DOI: 10.1016/j.biopsych.2005.05.011  0.72
2005 Csernansky JG, Martin M, Shah R, Bertchume A, Colvin J, Dong H. Cholinesterase inhibitors ameliorate behavioral deficits induced by MK-801 in mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 30: 2135-43. PMID 15956997 DOI: 10.1038/sj.npp.1300761  0.72
2005 Csernansky JG, Wang L, Swank J, Miller JP, Gado M, McKeel D, Miller MI, Morris JC. Preclinical detection of Alzheimer's disease: hippocampal shape and volume predict dementia onset in the elderly. Neuroimage. 25: 783-92. PMID 15808979 DOI: 10.1016/j.neuroimage.2004.12.036  0.72
2005 Dong H, Csernansky CA, Martin MV, Bertchume A, Vallera D, Csernansky JG. Acetylcholinesterase inhibitors ameliorate behavioral deficits in the Tg2576 mouse model of Alzheimer's disease. Psychopharmacology. 181: 145-52. PMID 15778881 DOI: 10.1007/s00213-005-2230-6  0.72
2005 Selemon LD, Wang L, Nebel MB, Csernansky JG, Goldman-Rakic PS, Rakic P. Direct and indirect effects of fetal irradiation on cortical gray and white matter volume in the macaque. Biological Psychiatry. 57: 83-90. PMID 15607304 DOI: 10.1016/j.biopsych.2004.10.014  0.72
2004 Csernansky JG, Hamstra J, Wang L, McKeel D, Price JL, Gado M, Morris JC. Correlations between antemortem hippocampal volume and postmortem neuropathology in AD subjects. Alzheimer Disease and Associated Disorders. 18: 190-5. PMID 15592129  0.72
2004 Ratnanather JT, Wang L, Nebel MB, Hosakere M, Han X, Csernansky JG, Miller MI. Validation of semiautomated methods for quantifying cingulate cortical metrics in schizophrenia. Psychiatry Research. 132: 53-68. PMID 15546703 DOI: 10.1016/j.pscychresns.2004.07.003  0.72
2004 Csernansky JG, Wang L, Joshi SC, Ratnanather JT, Miller MI. Computational anatomy and neuropsychiatric disease: probabilistic assessment of variation and statistical inference of group difference, hemispheric asymmetry, and time-dependent change. Neuroimage. 23: S56-68. PMID 15501101 DOI: 10.1016/j.neuroimage.2004.07.025  0.72
2004 Dong H, Goico B, Martin M, Csernansky CA, Bertchume A, Csernansky JG. Modulation of hippocampal cell proliferation, memory, and amyloid plaque deposition in APPsw (Tg2576) mutant mice by isolation stress. Neuroscience. 127: 601-9. PMID 15283960 DOI: 10.1016/j.neuroscience.2004.05.040  0.72
2004 Hogan RE, Wang L, Bertrand ME, Willmore LJ, Bucholz RD, Nassif AS, Csernansky JG. MRI-based high-dimensional hippocampal mapping in mesial temporal lobe epilepsy. Brain : a Journal of Neurology. 127: 1731-40. PMID 15231583 DOI: 10.1093/brain/awh197  0.72
2004 Csernansky JG, Schindler MK, Splinter NR, Wang L, Gado M, Selemon LD, Rastogi-Cruz D, Posener JA, Thompson PA, Miller MI. Abnormalities of thalamic volume and shape in schizophrenia. The American Journal of Psychiatry. 161: 896-902. PMID 15121656 DOI: 10.1176/appi.ajp.161.5.896  0.72
2004 Goveas JS, Csernansky JG, Coccaro EF. Platelet serotonin content correlates inversely with life history of aggression in personality-disordered subjects. Psychiatry Research. 126: 23-32. PMID 15081624 DOI: 10.1016/j.psychres.2004.01.006  0.72
2004 Heydebrand G, Weiser M, Rabinowitz J, Hoff AL, DeLisi LE, Csernansky JG. Correlates of cognitive deficits in first episode schizophrenia. Schizophrenia Research. 68: 1-9. PMID 15037334 DOI: 10.1016/S0920-9964(03)00097-5  0.72
2003 Yushkevich P, Joshi S, Pizer SM, Csernansky JG, Wang LE. Feature selection for shape-based classification of biological objects. Information Processing in Medical Imaging : Proceedings of the ... Conference. 18: 114-25. PMID 15344451  0.72
2003 Miller MI, Hosakere M, Barker AR, Priebe CE, Lee N, Ratnanather JT, Wang L, Gado M, Morris JC, Csernansky JG. Labeled cortical mantle distance maps of the cingulate quantify differences between dementia of the Alzheimer type and healthy aging. Proceedings of the National Academy of Sciences of the United States of America. 100: 15172-7. PMID 14657370 DOI: 10.1073/pnas.2136624100  0.72
2003 Tepest R, Wang L, Miller MI, Falkai P, Csernansky JG. Hippocampal deformities in the unaffected siblings of schizophrenia subjects. Biological Psychiatry. 54: 1234-40. PMID 14643091 DOI: 10.1016/S0006-3223(03)00702-9  0.72
2003 Barch DM, Mathews JR, Buckner RL, Maccotta L, Csernansky JG, Snyder AZ. Hemodynamic responses in visual, motor, and somatosensory cortices in schizophrenia. Neuroimage. 20: 1884-93. PMID 14642498 DOI: 10.1016/S1053-8119(03)00449-X  0.72
2003 Wang L, Swank JS, Glick IE, Gado MH, Miller MI, Morris JC, Csernansky JG. Changes in hippocampal volume and shape across time distinguish dementia of the Alzheimer type from healthy aging. Neuroimage. 20: 667-82. PMID 14568443 DOI: 10.1016/S1053-8119(03)00361-6  0.72
2003 Dong H, Csernansky CA, Chu Y, Csernansky JG. Intracerebroventricular kainic acid administration to neonatal rats alters interneuron development in the hippocampus. Brain Research. Developmental Brain Research. 145: 81-92. PMID 14519496 DOI: 10.1016/S0165-3806(03)00216-5  0.72
2003 Ashburner J, Csernansky JG, Davatzikos C, Fox NC, Frisoni GB, Thompson PM. Computer-assisted imaging to assess brain structure in healthy and diseased brains. The Lancet. Neurology. 2: 79-88. PMID 12849264 DOI: 10.1016/S1474-4422(03)00304-1  0.72
2003 Csernansky JG. Treatment of schizophrenia: preventing the progression of disease. The Psychiatric Clinics of North America. 26: 367-79. PMID 12778839 DOI: 10.1016/S0193-953X(02)00113-2  0.72
2003 Bardgett ME, Boeckman R, Krochmal D, Fernando H, Ahrens R, Csernansky JG. NMDA receptor blockade and hippocampal neuronal loss impair fear conditioning and position habit reversal in C57Bl/6 mice. Brain Research Bulletin. 60: 131-42. PMID 12725901 DOI: 10.1016/S0361-9230(03)00023-6  0.72
2003 Dong H, Csernansky CA, Goico B, Csernansky JG. Hippocampal neurogenesis follows kainic acid-induced apoptosis in neonatal rats. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 1742-9. PMID 12629178  0.72
2003 Barch DM, Sheline YI, Csernansky JG, Snyder AZ. Working memory and prefrontal cortex dysfunction: specificity to schizophrenia compared with major depression. Biological Psychiatry. 53: 376-84. PMID 12614990 DOI: 10.1016/S0006-3223(02)01674-8  0.72
2003 Posener JA, Wang L, Price JL, Gado MH, Province MA, Miller MI, Babb CM, Csernansky JG. High-dimensional mapping of the hippocampus in depression. The American Journal of Psychiatry. 160: 83-9. PMID 12505805 DOI: 10.1176/appi.ajp.160.1.83  0.72
2002 Bardgett ME, Humphrey WM, Csernansky JG. The effects of excitotoxic hippocampal lesions in rats on risperidone- and olanzapine-induced locomotor suppression. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 27: 930-8. PMID 12464450 DOI: 10.1016/S0893-133X(02)00376-7  0.72
2002 Csernansky JG, Wang L, Jones D, Rastogi-Cruz D, Posener JA, Heydebrand G, Miller JP, Miller MI. Hippocampal deformities in schizophrenia characterized by high dimensional brain mapping. The American Journal of Psychiatry. 159: 2000-6. PMID 12450948 DOI: 10.1176/appi.ajp.159.12.2000  0.72
2002 Selemon LD, Goldman-Rakic PS, Csernansky JG, Rakic P, Loganovsky K. Comments on Schindler et al, "Abnormalities of thalamic volume and shape detected in fetally irradiated rhesus monkeys with high dimensional brain mapping" [1] (multiple letters) Biological Psychiatry. 52: 911-913. PMID 12399145 DOI: 10.1016/S0006-3223(02)01571-8  0.72
2002 Csernansky JG, Miller JP, McKeel D, Morris JC. Relationships among cerebrospinal fluid biomarkers in dementia of the Alzheimer type. Alzheimer Disease and Associated Disorders. 16: 144-9. PMID 12218644 DOI: 10.1097/00002093-200207000-00003  0.72
2002 Barch DM, Csernansky JG, Conturo T, Snyder AZ. Working and long-term memory deficits in schizophrenia: is there a common prefrontal mechanism? Journal of Abnormal Psychology. 111: 478-94. PMID 12150424 DOI: 10.1037/0021-843X.111.3.478  0.72
2002 Humphrey WM, Dong H, Csernansky CA, Csernansky JG. Immediate and delayed hippocampal neuronal loss induced by kainic acid during early postnatal development in the rat. Brain Research. Developmental Brain Research. 137: 1-12. PMID 12128249 DOI: 10.1016/S0165-3806(02)00344-9  0.72
2002 Csernansky JG, Schuchart EK. Relapse and rehospitalisation rates in patients with schizophrenia: effects of second generation antipsychotics. Cns Drugs. 16: 473-84. PMID 12056922  0.72
2002 Schindler MK, Wang L, Selemon LD, Goldman-Rakic PS, Rakic P, Csernansky JG. Abnormalities of thalamic volume and shape detected in fetally irradiated rhesus monkeys with high dimensional brain mapping. Biological Psychiatry. 51: 827-37. PMID 12007457 DOI: 10.1016/S0006-3223(01)01341-5  0.72
2002 Yin H, Bardgett ME, Csernansky JG. Kainic acid lesions disrupt fear-mediated memory processing. Neurobiology of Learning and Memory. 77: 389-401. PMID 11991765 DOI: 10.1006/nlme.2001.4037  0.72
2002 Curtin F, Stalman SLP, Lieberman J, Schneider L, Csernansky JG, Mahmoud R. Prevention of relapse in schizophrenia [2] (multiple letters) New England Journal of Medicine. 346: 1412-1413. PMID 11987323 DOI: 10.1056/NEJM200205023461816  0.72
2002 Shuer ML, Hoff AL, Kremen WS, Wieneke MH, Lauriello J, Blankfeld HM, Faustman WO, Csernansky JG, Nordahl TE. Neuropsychiatric testing and the menstrual cycle [10] (multiple letters) American Journal of Psychiatry. 159: 679-680. PMID 11925326 DOI: 10.1176/appi.ajp.159.4.679  0.72
2002 Csernansky JG, Mahmoud R, Brenner R. A comparison of risperidone and haloperidol for the prevention of relapse in patients with schizophrenia. The New England Journal of Medicine. 346: 16-22. PMID 11777998 DOI: 10.1056/NEJMoa002028  0.72
2002 Csernansky JG, Bardgett ME, Dong H, Humphrey W, Wang L. Hippocampal structure and the action of cholinomimetic drugs Drug Development Research. 56: 531-540. DOI: 10.1002/ddr.10106  0.72
2001 Wang L, Joshi SC, Miller MI, Csernansky JG. Statistical analysis of hippocampal asymmetry in schizophrenia. Neuroimage. 14: 531-45. PMID 11506528 DOI: 10.1006/nimg.2001.0830  0.72
2001 Csernansky JG. Structural MRI as a tool for the study of neurotoxicity and neurodegenerative disorders. Journal of Analytical Toxicology. 25: 414-8. PMID 11499899  0.72
2001 Hoff AL, Kremen WS, Wieneke MH, Lauriello J, Blankfeld HM, Faustman WO, Csernansky JG, Nordahl TE. Association of estrogen levels with neuropsychological performance in women with schizophrenia. The American Journal of Psychiatry. 158: 1134-9. PMID 11431236 DOI: 10.1176/appi.ajp.158.7.1134  0.72
2001 Humphrey WM, Bardgett ME, Montgomery EM, Taylor GT, Csernansky JG. Methods for inducing neuronal loss in preweanling rats using intracerebroventricular infusion of kainic acid. Brain Research. Brain Research Protocols. 7: 1-10. PMID 11275518 DOI: 10.1016/S1385-299X(00)00055-6  0.72
2000 Csernansky JG, Wang L, Joshi S, Miller JP, Gado M, Kido D, McKeel D, Morris JC, Miller MI. Early DAT is distinguished from aging by high-dimensional mapping of the hippocampus. Dementia of the Alzheimer type. Neurology. 55: 1636-43. PMID 11113216  0.72
2000 Miller MI, Massie AB, Ratnanather JT, Botteron KN, Csernansky JG. Bayesian construction of geometrically based cortical thickness metrics. Neuroimage. 12: 676-87. PMID 11112399 DOI: 10.1006/nimg.2000.0666  0.72
2000 Hoff AL, Sakuma M, Razi K, Heydebrand G, Csernansky JG, DeLisi LE. Lack of association between duration of untreated illness and severity of cognitive and structural brain deficits at the first episode of schizophrenia. The American Journal of Psychiatry. 157: 1824-8. PMID 11058480 DOI: 10.1176/appi.ajp.157.11.1824  0.72
1999 Csernansky JG, Posener JA. Laboratory tests to aid in psychiatric diagnosis: are we making progress? Archives of General Psychiatry. 56: 405-6. PMID 10232293 DOI: 10.1001/archpsyc.56.5.405  0.72
1999 Montgomery EM, Bardgett ME, Lall B, Csernansky CA, Csernansky JG. Delayed neuronal loss after administration of intracerebroventricular kainic acid to preweanling rats. Brain Research. Developmental Brain Research. 112: 107-16. PMID 9974164 DOI: 10.1016/S0165-3806(98)00161-8  0.72
1999 Faustman WO, Bardgett M, Faull KF, Pfefferbaum A, Csernansky JG. Cerebrospinal fluid glutamate inversely correlates with positive symptom severity in unmedicated male schizophrenic/schizoaffective patients. Biological Psychiatry. 45: 68-75. PMID 9894577 DOI: 10.1016/S0006-3223(98)00207-8  0.72
1999 Marsh L, Lim KO, Hoff AL, Harris D, Beal M, Minn K, Faustman WO, Csernansky JG, Sullivan EV, Pfefferbaum A. Severity of schizophrenia and magnetic resonance imaging abnormalities: a comparison of state and veterans hospital patients. Biological Psychiatry. 45: 49-61. PMID 9894575 DOI: 10.1016/S0006-3223(98)00197-8  0.72
1998 Csernansky JG, Csernansky CA, Kogelman L, Montgomery EM, Bardgett ME. Progressive neurodegeneration after intracerebroventricular kainic acid administration in rats: implications for schizophrenia? Biological Psychiatry. 44: 1143-50. PMID 9836017 DOI: 10.1016/S0006-3223(98)00019-5  0.72
1998 Csernansky JG, Joshi S, Wang L, Haller JW, Gado M, Miller JP, Grenander U, Miller MI. Hippocampal morphometry in schizophrenia by high dimensional brain mapping. Proceedings of the National Academy of Sciences of the United States of America. 95: 11406-11. PMID 9736749 DOI: 10.1073/pnas.95.19.11406  0.72
1998 Roe DL, Bardgett ME, Csernansky CA, Csernansky JG. Induction of Fos protein by antipsychotic drugs in rat brain following kainic acid-induced limbic-cortical neuronal loss. Psychopharmacology. 138: 151-8. PMID 9718284 DOI: 10.1007/s002130050657  0.72
1998 Huntley DA, Cho DW, Christman J, Csernansky JG. Predicting length of stay in an acute psychiatric hospital. Psychiatric Services (Washington, D.C.). 49: 1049-53. PMID 9712211  0.72
1998 Newcomer JW, Craft S, Askins K, Hershey T, Bardgett ME, Csernansky JG, Gagliardi AE, Vogler G. Glucocorticoid interactions with memory function in schizophrenia. Psychoneuroendocrinology. 23: 65-72. PMID 9618753 DOI: 10.1016/S0306-4530(97)00081-4  0.72
1998 Csernansky JG, Bardgett ME. Limbic-cortical neuronal damage and the pathophysiology of schizophrenia. Schizophrenia Bulletin. 24: 231-48. PMID 9613623  0.72
1998 Csernansky JG, Grace AA. New models of the pathophysiology of schizophrenia: editors' introduction. Schizophrenia Bulletin. 24: 185-7. PMID 9613619  0.72
1998 Bardgett ME, Jackson JL, Taylor BM, Csernansky JG. The effects of kainic acid lesions on locomotor responses to haloperidol and clozapine. Psychopharmacology. 135: 270-8. PMID 9498730 DOI: 10.1007/s002130050509  0.72
1998 Sheline YI, Miller K, Bardgett ME, Csernansky JG. Higher cerebrospinal fluid MHPG in subjects with dementia of the Alzheimer type: Relationship with cognitive dysfunction American Journal of Geriatric Psychiatry. 6: 155-161. DOI: 10.1097/00019442-199805000-00009  0.72
1997 Marsh L, Harris D, Lim KO, Beal M, Hoff AL, Minn K, Csernansky JG, DeMent S, Faustman WO, Sullivan EV, Pfefferbaum A. Structural magnetic resonance imaging abnormalities in men with severe chronic schizophrenia and an early age at clinical onset. Archives of General Psychiatry. 54: 1104-12. PMID 9400346  0.72
1997 Bardgett ME, Salaris SL, Jackson JL, Harding J, Csernansky JG. The effects of kainic acid lesions on dopaminergic responses to haloperidol and clozapine. Psychopharmacology. 133: 142-51. PMID 9342780 DOI: 10.1007/s002130050384  0.72
1997 Coccaro EF, Kavoussi RJ, Sheline YI, Berman ME, Csernansky JG. Impulsive aggression in personality disorder correlates with platelet 5-HT2A receptor binding. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 16: 211-6. PMID 9138437 DOI: 10.1016/S0893-133X(96)00194-7  0.72
1997 Bardgett ME, Jacobs PS, Jackson JL, Csernansky JG. Kainic acid lesions enhance locomotor responses to novelty, saline, amphetamine, and MK-801. Behavioural Brain Research. 84: 47-55. PMID 9079771 DOI: 10.1016/S0166-4328(96)00132-5  0.72
1997 Haller JW, Banerjee A, Christensen GE, Gado M, Joshi S, Miller MI, Sheline Y, Vannier MW, Csernansky JG. Three-dimensional hippocampal MR morphometry with high-dimensional transformation of a neuroanatomic atlas. Radiology. 202: 504-10. PMID 9015081 DOI: 10.1148/radiology.202.2.9015081  0.72
1997 Sheline Y, Bardgett ME, Csernansky JG. Correlated reductions in cerebrospinal fluid 5-HIAA and MHPG concentrations after treatment with selective serotonin reuptake inhibitors. Journal of Clinical Psychopharmacology. 17: 11-4. PMID 9004051 DOI: 10.1097/00004714-199702000-00003  0.72
1997 Joshi SC, Banerjee A, Christensen GE, Csernansky JG, Hailer JW, Miller MI, Wang L. Gaussian random fields on sub-manifolds for characterizing brain surfaces* Lecture Notes in Computer Science (Including Subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics). 1230: 381-386.  0.72
1996 Hoff AL, Faustman WO, Wieneke M, Espinoza S, Costa M, Wolkowitz O, Csernansky JG. The effects of clozapine on symptom reduction, neurocognitive function, and clinical management in treatment-refractory state hospital schizophrenic inpatients. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 15: 361-9. PMID 8887990 DOI: 10.1016/0893-133X(95)00242-6  0.72
1996 Nelson EC, Cloninger CR, Przybeck TR, Csernansky JG. Platelet serotonergic markers and Tridimensional Personality Questionnaire measures in a clinical sample. Biological Psychiatry. 40: 271-8. PMID 8871773 DOI: 10.1016/0006-3223(95)00381-9  0.72
1996 Hoff AL, Harris D, Faustman WO, Beal M, DeVilliers D, Mone RD, Moses JA, Csernansky JG. A neuropsychological study of early onset schizophrenia. Schizophrenia Research. 20: 21-8. PMID 8794490 DOI: 10.1016/0920-9964(95)00065-8  0.72
1996 Lim KO, Harris D, Beal M, Hoff AL, Minn K, Csernansky JG, Faustman WO, Marsh L, Sullivan EV, Pfefferbaum A. Gray matter deficits in young onset schizophrenia are independent of age of onset. Biological Psychiatry. 40: 4-13. PMID 8780849 DOI: 10.1016/0006-3223(95)00356-8  0.72
1996 Csernansky JG, Bardgett ME, Sheline YI, Morris JC, Olney JW. CSF excitatory amino acids and severity of illness in Alzheimer's disease. Neurology. 46: 1715-20. PMID 8649576  0.72
1996 Coccaro EF, Kavoussi RJ, Sheline YI, Lish JD, Csernansky JG. Impulsive aggression in personality disorder correlates with tritiated paroxetine binding in the platelet. Archives of General Psychiatry. 53: 531-6. PMID 8639036  0.72
1996 Haller JW, Christensen GE, Joshi SC, Newcomer JW, Miller MI, Csernansky JG, Vannier MW. Hippocampal MR imaging morphometry by means of general pattern matching. Radiology. 199: 787-91. PMID 8638006 DOI: 10.1148/radiology.199.3.8638006  0.72
1996 Sheline YI, Wang PW, Gado MH, Csernansky JG, Vannier MW. Hippocampal atrophy in recurrent major depression. Proceedings of the National Academy of Sciences of the United States of America. 93: 3908-13. PMID 8632988 DOI: 10.1073/pnas.93.9.3908  0.72
1995 Nelson EC, Sheline YI, Bardgett ME, Jackson JL, Csernansky JG. Platelet paroxetine binding in major depressive disorder with and without comorbid obsessive-compulsive disorder. Psychiatry Research. 58: 117-25. PMID 8570763 DOI: 10.1016/0165-1781(95)02695-S  0.72
1995 Bardgett ME, Jackson JL, Taylor GT, Csernansky JG. Kainic acid decreases hippocampal neuronal number and increases dopamine receptor binding in the nucleus accumbens: an animal model of schizophrenia. Behavioural Brain Research. 70: 153-64. PMID 8561906 DOI: 10.1016/0166-4328(95)80005-0  0.72
1995 Csernansky JG, Csernansky CA. Epileptic psychoses and dopamine receptor sensitivity. Biological Psychiatry. 37: 64-5. PMID 7893864 DOI: 10.1016/0006-3223(94)00196-A  0.72
1995 Sheline YI, Bardgett ME, Jackson JL, Newcomer JW, Csernansky JG. Platelet serotonin markers and depressive symptomatology. Biological Psychiatry. 37: 442-7. PMID 7786957 DOI: 10.1016/0006-3223(94)00160-5  0.72
1995 Sheline YI, Black KJ, Bardgett ME, Csernansky JG. Platelet binding characteristics distinguish placebo responders from nonresponders in depression. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 12: 315-22. PMID 7576008 DOI: 10.1016/0893-133X(94)00097-J  0.72
1994 Bardgett ME, Taylor GT, Csernansky JG, Newcomer JW, Nock B. Chronic corticosterone treatment impairs spontaneous alternation behavior in rats. Behavioral and Neural Biology. 61: 186-90. PMID 8204085 DOI: 10.1016/S0163-1047(05)80074-3  0.72
1994 Zipursky RB, Marsh L, Lim KO, DeMent S, Shear PK, Sullivan EV, Murphy GM, Csernansky JG, Pfefferbaum A. Volumetric MRI assessment of temporal lobe structures in schizophrenia. Biological Psychiatry. 35: 501-16. PMID 8038294 DOI: 10.1016/0006-3223(94)90097-3  0.72
1994 Newcomer JW, Miller LS, Faustman WO, Wetzel MW, Vogler GP, Csernansky JG. Correlations between akathisia and residual psychopathology: a by-product of neuroleptic-induced dysphoria. The British Journal of Psychiatry : the Journal of Mental Science. 164: 834-8. PMID 7952993  0.72
1994 Ford JM, White PM, Csernansky JG, Faustman WO, Roth WT, Pfefferbaum A. ERPs in schizophrenia: effects of antipsychotic medication. Biological Psychiatry. 36: 153-70. PMID 7948453 DOI: 10.1016/0006-3223(94)91221-1  0.72
1994 Csernansky JG, Newcomer JW. Are there neurochemical indicators of risk for schizophrenia? Schizophrenia Bulletin. 20: 75-88. PMID 7910978 DOI: 10.1093/schbul/20.1.75  0.72
1994 Csernansky JG, Newcomer JW, Jackson K, Lombrozo L, Faull KF, Zipursky R, Pfefferbaum A, Faustman WO. Effects of raclopride treatment on plasma and CSF HVA: relationships with clinical improvement in male schizophrenics. Psychopharmacology. 116: 291-6. PMID 7534423 DOI: 10.1007/BF02245331  0.72
1994 Zarcone VP, Benson KL, Greene KA, Csernansky JG, Faull KF. The effect of chronic alprazolam on sleep and bioamine metabolites in depression. Journal of Clinical Psychopharmacology. 14: 36-40. PMID 7512100  0.72
1993 Csernansky JG, Sheline YI. Abnormalities of serotonin metabolism and nonpsychotic psychiatric disorders. Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists. 5: 275-81. PMID 8312985  0.72
1992 Newcomer JW, Riney SJ, Vinogradov S, Csernansky JG. Plasma prolactin and homovanillic acid as markers for psychopathology and abnormal movements after neuroleptic dose decrease. Psychopharmacology Bulletin. 28: 101-7. PMID 1609034  0.6
1992 Newcomer JW, Riney SJ, Vinogradov S, Csernansky JG. Plasma prolactin and homovanillic acid as markers for psychopathology and abnormal movements during maintenance haloperidol treatment in male patients with schizophrenia. Psychiatry Research. 41: 191-202. PMID 1594706  0.6
1992 Faustman WO, Bono MA, Moses JA, Csernansky JG. Season of birth and neuropsychological impairment in schizophrenia. The Journal of Nervous and Mental Disease. 180: 644-8. PMID 1402843  0.72
1991 Newcomer JW, Faustman WO, Whiteford HA, Moses JA, Csernansky JG. Symptomatology and cognitive impairment associate independently with post-dexamethasone cortisol concentrations in unmedicated schizophrenic patients. Biological Psychiatry. 29: 855-64. PMID 2049484 DOI: 10.1016/0006-3223(91)90052-N  0.72
1991 Faustman WO, King RJ, Faull KF, Moses JA, Benson KL, Zarcone VP, Csernansky JG. MMPI measures of impulsivity and depression correlate with CSF 5-HIAA and HVA in depression but not schizophrenia. Journal of Affective Disorders. 22: 235-9. PMID 1939932 DOI: 10.1016/0165-0327(91)90069-5  0.72
1991 Bellows EP, Barnes DE, Csernansky JG. Estimation of haloperidol concentrations in rat striatum after chronic treatment. Brain Research Bulletin. 26: 715-9. PMID 1933392 DOI: 10.1016/0361-9230(91)90165-G  0.72
1991 Miller LS, Faustman WO, Moses JA, Csernansky JG. Evaluating cognitive impairment in depression with the Luria-Nebraska Neuropsychological Battery: severity correlates and comparisons with nonpsychiatric controls. Psychiatry Research. 37: 219-27. PMID 1891505 DOI: 10.1016/0165-1781(91)90058-W  0.72
1990 Csernansky JG, Bellows EP, Barnes DE, Lombrozo L. Sensitization versus tolerance to the dopamine turnover-elevating effects of haloperidol: the effect of regular/intermittent dosing. Psychopharmacology. 101: 519-24. PMID 2388975 DOI: 10.1007/BF02244231  0.72
1990 Csernansky JG, Leiderman DB, Mandabach M, Moses JA. Psychopathology and limbic epilepsy: relationship to seizure variables and neuropsychological function. Epilepsia. 31: 275-80. PMID 2344845  0.72
1990 Leiderman DB, Csernansky JG, Moses JA. Neuroendocrinology and limbic epilepsy: relationships to psychopathology, seizure variables, and neuropsychological function. Epilepsia. 31: 270-4. PMID 2344844  0.72
1990 Faustman WO, Moses JA, Csernansky JG. Limitations of the Mini-Mental State Examination in predicting neuropsychological functioning in a psychiatric sample. Acta Psychiatrica Scandinavica. 81: 126-31. PMID 2327274  0.72
1990 Csernansky JG, Barnes DE, Bellows EP, Lombrozo L. Interrelationships between plasma homovanillic acid and indices of dopamine turnover in multiple brain areas during haloperidol and saline administration. Life Sciences. 46: 707-13. PMID 2314192 DOI: 10.1016/0024-3205(90)90076-4  0.72
1990 Petrie EC, Lombrozo L, Csernansky JG. A microassay for measuring synaptosomal 3H-dopamine and 3H-metabolite release. Brain Research Bulletin. 25: 423-7. PMID 2292040  0.6
1990 Peabody CA, Warner MD, Markoff E, Hoffman AR, Wilson DM, Csernansky JG. Growth hormone response to growth hormone releasing hormone in depression and schizophrenia. Psychiatry Research. 33: 269-76. PMID 2243902 DOI: 10.1016/0165-1781(90)90043-5  0.72
1990 Petrie EC, Faustman WO, Moses JA, Lombrozo L, Csernansky JG. Correlates of rapid neuroleptic response in male patients with schizophrenia. Psychiatry Research. 33: 171-7. PMID 2243894 DOI: 10.1016/0165-1781(90)90071-C  0.72
1990 Barnes DE, Robinson B, Csernansky JG, Bellows EP. Sensitization versus tolerance to haloperidol-induced catalepsy: multiple determinants. Pharmacology, Biochemistry, and Behavior. 36: 883-7. PMID 2217518 DOI: 10.1016/0091-3057(90)90094-X  0.72
1990 Vinogradov S, Csernansky JG. Postpartum psychosis with abnormal movements: dopamine supersensitivity unmasked by withdrawal of endogenous estrogens? The Journal of Clinical Psychiatry. 51: 365-6. PMID 2211549  0.72
1990 Warner MD, Peabody CA, Csernansky JG. Olfactory functioning in schizophrenia and depression. Biological Psychiatry. 27: 457-8. PMID 2178695 DOI: 10.1016/0006-3223(90)90557-I  0.72
1990 Jibson M, Faull KF, Csernansky JG. Intercorrelations among monoamine metabolite concentrations in human lumbar CSF are not due to a shared acid transport system. Biological Psychiatry. 28: 595-602. PMID 1699614 DOI: 10.1016/0006-3223(90)90397-K  0.72
1990 Csernansky JG, King RJ, Faustman WO, Moses JA, Poscher ME, Faull KF. 5-HIAA in cerebrospinal fluid and deficit schizophrenic characteristics. The British Journal of Psychiatry : the Journal of Mental Science. 156: 501-7. PMID 1696842  0.72
1990 Faustman WO, Faull KF, Whiteford HA, Borchert C, Csernansky JG. CSF 5-HIAA, serum cortisol, and age differentially predict vegetative and cognitive symptoms in depression. Biological Psychiatry. 27: 311-8. PMID 1689187 DOI: 10.1016/0006-3223(90)90005-M  0.72
1989 Faustman WO, Moses JA, Csernansky JG, White PA. Correlations between the MMPI and the Brief Psychiatric Rating Scale in schizophrenic and schizoaffective patients. Psychiatry Research. 28: 135-43. PMID 2748768 DOI: 10.1016/0165-1781(89)90041-3  0.72
1989 Faull KF, King RJ, Barchas JD, Csernansky JG. CSF phenylacetic acid and hostility in paranoid schizophrenia. Psychiatry Research. 30: 111-8. PMID 2616681 DOI: 10.1016/0165-1781(89)90152-2  0.72
1989 Hicks PB, Vinogradov S, Riney SJ, Su K, Csernansky JG. A preliminary dose-ranging trial of proglumide for the treatment of refractory schizophrenics. Journal of Clinical Psychopharmacology. 9: 209-12. PMID 2567742  0.6
1989 Prosser ES, Pruthi R, Csernansky JG. Differences in the time course of dopaminergic supersensitivity following chronic administration of haloperidol, molindone, or sulpiride. Psychopharmacology. 99: 109-16. PMID 2506596  0.52
1988 Uhr SB, Jackson K, Berger PA, Csernansky JG. Effects of verapamil administration on negative symptoms of chronic schizophrenia. Psychiatry Research. 23: 351-2. PMID 3387506 DOI: 10.1016/0165-1781(88)90027-3  0.72
1988 Csernansky JG, Tacke U, Rusen D, Hollister LE. The effect of benzodiazepines on tardive dyskinesia symptoms. Journal of Clinical Psychopharmacology. 8: 154-5. PMID 3372715  0.72
1988 Csernansky JG, Riney SJ, Lombrozo L, Overall JE, Hollister LE. Double-blind comparison of alprazolam, diazepam, and placebo for the treatment of negative schizophrenic symptoms. Archives of General Psychiatry. 45: 655-9. PMID 3289523 DOI: 10.1001/archpsyc.1988.01800310063008  0.72
1988 Whiteford HA, Riney SJ, Savala RA, Csernansky JG. Dexamethasone nonsuppression in chronic schizophrenia. Acta Psychiatrica Scandinavica. 77: 58-62. PMID 3273153  0.6
1988 Faustman WO, Moses JA, Csernansky JG. Luria-Nebraska performance and symptomatology in unmedicated schizophrenic patients. Psychiatry Research. 26: 29-34. PMID 3237904 DOI: 10.1016/0165-1781(88)90084-4  0.72
1988 Csernansky JG, Kerr S, Pruthi R, Prosser ES. Mesolimbic dopamine receptor increases two weeks following hippocampal kindling. Brain Research. 449: 357-60. PMID 2969276  0.52
1988 Csernansky JG, Mellentin J, Beauclair L, Lombrozo L. Mesolimbic dopaminergic supersensitivity following electrical kindling of the amygdala. Biological Psychiatry. 23: 285-94. PMID 2962647  0.6
1988 Prosser ES, Csernansky JG, Hollister LE. Differences in the time course of haloperidol-induced up-regulation of rat striatal and mesolimbic dopamine receptors. Life Sciences. 43: 715-20. PMID 2901023 DOI: 10.1016/0024-3205(88)90143-9  0.72
1988 Csernansky JG, Faull KF, Pfefferbaum A. Seasonal changes of CSF monoamine metabolites in psychiatric patients: what is the source? Psychiatry Research. 25: 361-3. PMID 2460883 DOI: 10.1016/0165-1781(88)90105-9  0.72
1987 Beauclair L, Vinogradov S, Riney SJ, Csernansky JG, Hollister LE. An adjunctive role for ascorbic acid in the treatment of schizophrenia? Journal of Clinical Psychopharmacology. 7: 282-3. PMID 3624518  0.72
1987 Whiteford HA, Peabody CA, Thiemann S, Kraemer HC, Csernansky JG, Berger PA. The effect of age on baseline and postdexamethasone cortisol levels in major depressive disorder. Biological Psychiatry. 22: 1029-32. PMID 3607127 DOI: 10.1016/0006-3223(87)90013-8  0.72
1987 Thiemann S, Csernansky JG, Berger PA. Rating scales in research: the case of negative symptoms. Psychiatry Research. 20: 47-55. PMID 3562690 DOI: 10.1016/0165-1781(87)90122-3  0.72
1987 Whiteford HA, Riney SJ, Csernansky JG. Distinguishing depressive and negative symptoms in chronic schizophrenia. Psychopathology. 20: 234-6. PMID 3454446  0.6
1987 Finnegan KT, Terwilliger MM, Berger PA, Hollister LE, Csernansky JG. A comparison of the neurochemical and behavioral effects of clenbuterol and desipramine. European Journal of Pharmacology. 134: 131-6. PMID 3032650 DOI: 10.1016/0014-2999(87)90158-0  0.72
1987 Whiteford HA, Peabody CA, Csernansky JG, Warner MD, Berger PA. Elevated baseline and postdexamethasone cortisol levels. A reflection of severity or endogeneity? Journal of Affective Disorders. 12: 199-202. PMID 2956304 DOI: 10.1016/0165-0327(87)90027-9  0.72
1987 Whiteford HA, Peabody CA, Warner MD, Berger PA, Csernansky JG. Maintenance therapies in schizophrenia. The Medical Journal of Australia. 147: 240-2. PMID 2890085  0.72
1987 Prosser ES, Csernansky JG, Kaplan J, Thiemann S, Becker TJ, Hollister LE. Depression, parkinsonian symptoms, and negative symptoms in schizophrenics treated with neuroleptics. The Journal of Nervous and Mental Disease. 175: 100-5. PMID 2879880  0.72
1986 Csernansky JG, Csernansky CA, King R, Hollister LE. Oscillations in apomorphine-induced stereotypies during 1 year of apomorphine administration. Biological Psychiatry. 21: 402-5. PMID 3955116 DOI: 10.1016/0006-3223(86)90170-8  0.72
1986 Csernansky JG, Csernansky CA, Mellentin JD, Hollister LE. Carbamazepine and dopaminergic supersensitivity. Biological Psychiatry. 21: 238-9. PMID 3947704 DOI: 10.1016/0006-3223(86)90159-9  0.72
1986 Whiteford HA, Peabody CA, Csernansky JG, Berger PA. The severity of depression and nonsuppression on the DST. The American Journal of Psychiatry. 143: 1634-5. PMID 3789227  0.72
1986 Csernansky JG, Vinogradov S, Prosser E, Kaplan J, Berger PA, Hollister LE. Associations among plasma prolactin levels, tardive dyskinesia, and paranoia in treated schizophrenics: relevance to supersensitivity psychosis. Psychopharmacology Bulletin. 22: 897-9. PMID 2879311  0.72
1986 Vinogradov S, Reiss AL, Csernansky JG. Clonidine therapy in withdrawal from high-dose alprazolam treatment. The American Journal of Psychiatry. 143: 1188. PMID 2875667  0.72
1986 Csernansky JG, Prosser E, Kaplan J, Mahler E, Berger PA, Hollister LE. Possible associations among plasma prolactin levels, tardive dyskinesia, and paranoia in treated male schizophrenics. Biological Psychiatry. 21: 632-42. PMID 2871874 DOI: 10.1016/0006-3223(86)90124-1  0.72
1985 Csernansky JG, Csernansky CA, Hollister LE. 3[H]-Sulpiride labels mesolimbic non-dopaminergic sites that bind antidepressant drugs. Experientia. 41: 1419-21. PMID 4065296 DOI: 10.1007/BF01950013  0.72
1985 Csernansky JG, Csernansky CA, Bonnet KA, Hollister LE. Dopaminergic supersensitivity follows ferric chloride-induced limbic seizures. Biological Psychiatry. 20: 723-33. PMID 4039950 DOI: 10.1016/0006-3223(85)90151-9  0.72
1985 Csernansky CA, Csernansky JG, Hollister LE. A comparison between centrifugation and filtration as a means to separate bound and unbound ligand during 3[H]-spiroperidol binding. Journal of Pharmacological Methods. 13: 187-91. PMID 3999754 DOI: 10.1016/0160-5402(85)90018-X  0.72
1985 Csernansky JG, Csernansky CA, Glick SA, Hollister LE. Lidocaine kindling is accompanied by an increase in apomorphine stereotypy and mesolimbic dopamine D2 receptor density. Psychopharmacology Bulletin. 21: 707-11. PMID 2930865  0.72
1985 Csernansky JG, Kaplan J, Hollister LE. Problems in classification of schizophrenics as neuroleptic responders and nonresponders. The Journal of Nervous and Mental Disease. 173: 325-31. PMID 2860202  0.72
1984 Csernansky JG, Csernansky CA, Hollister LE. Distinct effects of two stresses on the behavioral response to apomorphine. Life Sciences. 35: 1513-8. PMID 6541282 DOI: 10.1016/0024-3205(84)90169-3  0.72
1984 Csernansky JG, Lombrozo L, Gulevich GD, Hollister LE. Treatment of negative schizophrenic symptoms with alprazolam: a preliminary open-label study. Journal of Clinical Psychopharmacology. 4: 349-52. PMID 6150950  0.72
1983 Csernansky JG, Holman CA, Hollister LE. Variability and the dopamine hypothesis of schizophrenia. Schizophrenia Bulletin. 9: 325-8. PMID 6622990  0.72
1983 Csernansky JG, Holman CA, Bonnet KA, Grabowsky K, King R, Hollister LE. Dopaminergic supersensitivity at distant sites following induced epileptic foci. Life Sciences. 32: 385-90. PMID 6402628 DOI: 10.1016/0024-3205(83)90084-X  0.72
1983 Magliozzi JR, Kanter SL, Csernansky JG, Hollister LE. Detection of marijuana use in psychiatric patients by determination of urinary delta-9-tetrahydrocannabinol-11-oic acid. The Journal of Nervous and Mental Disease. 171: 246-9. PMID 6300320  0.72
1983 Csernansky JG, Kaplan J, Holman CA, Hollister LE. Serum neuroleptic activity, prolactin, and tardive dyskinesia in schizophrenic outpatients. Psychopharmacology. 81: 115-8. PMID 6138793 DOI: 10.1007/BF00429003  0.72
1983 Csernansky JG, Yesavage JA, Maloney W, Kaplan J. The treatment response scale: a retrospective method of assessing response to neuroleptics. The American Journal of Psychiatry. 140: 1210-3. PMID 6137150  0.56
1982 Csernansky JG, Friedhoff AJ, Bonnet KA. Early supersensitive changes in [3H] spiroperidol binding in the isolated striatum. Biochemical and Biophysical Research Communications. 105: 117-20. PMID 6124243  0.52
1982 Yesavage JA, Bourgeois M, Kraemer H, Csernansky JG, Berger PA. Prevalence of tardive dyskinesia in 3140 French inpatients. The Journal of Nervous and Mental Disease. 170: 111-2. PMID 6120209  0.72
1981 Csernansky JG, Grabowski K, Cervantes J, Kaplan J, Yesavage JA. Fluphenazine decanoate and tardive dyskinesia: a possible association. The American Journal of Psychiatry. 138: 1362-5. PMID 7294195  0.56
Show low-probability matches.